GTBP vs LHX · $17.4M cap vs P/E 34, rev $5.88B
GT Biopharma Inc (GTBP) versus L3Harris Technologies Inc (LHX) — a side-by-side from cached financials, not a winner call.
GT Biopharma Inc (GTBP) is a biotechnology company listed on NASDAQ.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
GTBP does not have a complete income-statement cache yet.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
GTBP currently screens at market cap $17.4M. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Not investment advice. Open the GTBP and LHX stock pages for the full models.
Not investment advice.